We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Submit your research today!

Your valuable research in Expert Opinion on Drug Discovery - The discovery and development of RNA-based therapeutics

About the special issue

RNA-based therapeutics are an emerging and exciting field that has gained considerable traction with the advent of mRNA based vaccines for the treatment of SARS-COV-2. However, RNA-based therapeutics have considerable potential that goes way beyond their current use and the aim of this issue is to capture the novel discovery and development strategies that are underway/have been utilized to produce these exciting treatment options.

The issue intends to cover a broad range of topics including the discovery of: oligonucleotides, aptamers, small interfering RNAs, microRNAs, and messenger RNA. We will also cover the discovery and development of small molecule drugs that target RNA.

 

Submission Information

3-5 week submission deadline: 1st June 2022
7-9 week submission deadline: 15th June 2022

Learn more about preparing your manuscript by visiting the Instructions for Authors page.

Commissioning Editor: David Grech

Submit here

By publishing in Expert Opinion on Drug Discovery you will:

  1. Gain recognition from an international audience and increase your opportunities for future collaboration 
  2. Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site  
  3. Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works  
  4. Increase the discoverability of your research with MEDLINE listings and more